Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 75,948 | 0 | 0 | 0 | 4,360 |
| Other current assets | 0 | 0 | 0 | 0 | 140 |
| TOTAL | $76,873 | $0 | $0 | $0 | $4,500 |
| Non-Current Assets | |||||
| PPE Net | 25 | N/A | N/A | N/A | N/A |
| TOTAL | $25 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $76,898 | $0 | $0 | $0 | $4,530 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 997 | 0 | 0 | 0 | 640 |
| Accrued Expenses | 912 | 0 | 0 | 0 | 670 |
| TOTAL | $1,910 | $0 | $0 | $0 | $1,520 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,741 | 0 | 0 | 0 | 0 |
| TOTAL | $9,741 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $11,651 | $0 | $0 | $0 | $1,520 |
| Shareholders' Equity | |||||
| Common Shares | 1 | 0 | 0 | 0 | 0 |
| Retained earnings | -69,675 | 0 | 0 | 0 | -58,850 |
| Other shareholders' equity | 0 | 0 | 0 | 0 | 59,690 |
| TOTAL | $65,247 | $0 | $0 | $0 | $3,000 |
| Total Liabilities And Equity | $76,898 | $0 | $0 | $0 | $4,520 |